Table 3.
Parameters | No | Event | Median PFS | Log-rank | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|---|---|---|---|
(95% CI) | P value | HR (95% CI) | P value | HR (95% CI) | P value | |||
FES SUVmax | ||||||||
≥ 6.5 | 23 | 14 | 21.6(13.5–29.6) | 0.258 | 0.63(0.28–1.42) | 0.262 | NA | |
< 6.5 | 23 | 10 | 29.4(13.4–45.4) | |||||
FES Hot5 lesions | ||||||||
≥ 8.1 | 23 | 13 | 23.6(14.3–32.8) | 0.575 | 0.79(0.35–1.79) | 0.576 | NA | |
< 8.1 | 23 | 11 | 23.9(9.3–38.5) | |||||
FES HI a | ||||||||
≥ 1.50 | 23 | 14 | 16.5(4.4–28.6) | 0.004* | 0.27(0.10–0.70) | 0.007* | NA | |
< 1.50 | 23 | 10 | 26.5(21.8–32.2) |
PFS Progression-free survival; CI Confidence interval; HR Hazard ratio; SUVmax Maximum standard uptake value; SUVmean Mean standard uptake value; HI Heterogeneity index
a HI = SUVmax/SUVmean; * Indicates statistically significant differences (P < 0.05)